GUD.TO Tin tức Forex

Specialty pharmaceutical company Knight Therapeutics Inc. (GUD.TO) announced Thursday it has entered into an exclusive license agreement with Amneal Pharmaceuticals, Inc. (AMRX), granting Knight the exclusive rights to seek regulatory approval and commercialize IPX203 in Canada and Latin America.